Rheumatil Tablet is owned by Dabur India Ltd, which is headquartered in India. We trace ownership to the ultimate parent — not just the local subsidiary — using public corporate filings and disclosures.

Our ownership score is the weighted sum of seven signals: ultimate ownership (25%), country of control (15%), profit retention (15%), supply-chain localization (15%), manufacturing in India (10%), brand/IP ownership (10%), and leadership control (10%). Full methodology is published at /methodology.

Indian-controlled alternatives in the same category include Yoga Bar, Himalayan Organics, Stresscom, Warrior. Each alternative is verified against the same ownership framework — strategic control, equity, and economic value retained in India.

Rheumatil Tablet is primarily mapped to Personal Care. We map every brand to its primary category and segment so you can compare like-for-like alternatives instead of unrelated products.

We re-verify ownership data on a rolling weekly cadence. Major changes — parent company shifts, classification flips, or score moves greater than 5 points — are published in the public ownership change log within 24 hours.